IDXXIdexx Laboratories
The financials
Idexx Laboratories by the numbers
Idexx Laboratories (IDXX) reported revenue of $1.21B in Q3 2026 (quarter ended Sep 30, 2026), up 9.9% from the same quarter a year earlier. That came with a gross margin of 63% and net income of $317M (26% of revenue). For the full year FY2025, revenue was $4.30B (+10% year on year) and net income $1.06B. Its largest product in Q2 2026 (quarter ended Jun 30, 2026) was Vet Lab Consumables at $430M, 35% of the disclosed total, just ahead of Reference Laboratory Diagnostic And Consulting Services at 33%. The next results filing is expected around Feb 1, 2027, the same week as a year ago.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $1.21B | $1.11B | +9.9% |
| Gross profit | $764M | $683M | +12% |
| Operating income | $402M | $355M | +13% |
| Net income | $317M | $275M | +15% |
| Diluted EPS | $4.01 | $3.40 | +18% |
| Product | Revenue | Share |
|---|---|---|
| Vet Lab Consumables | $430M | 35% |
| Reference Laboratory Diagnostic And Consulting Services | $407M | 33% |
| Rapid Assay Products | $102M | 8.4% |
| Veterinary Software Services And Diagnostic Imaging Systems | $96M | 7.9% |
| Recurring | $76M | 6.3% |
| CAG Diagnostic Capital Instruments | $47M | 3.9% |
| CAG Diagnostics Service And Accessories | $36M | 3.0% |
| Systems And Hardware | $20M | 1.6% |
Over its last three fiscal years Idexx Laboratories booked income tax of 20.1% of its pretax profit, close to the 21.3% median for US companies in our tax study.
Business segments
Revenue split by product segment, from SEC XBRL filings.
- Vet Lab Consumables$430.3M$430.3Mvs last quarter +4.3%vs a year ago +15%+4.3%+15%
- Reference Laboratory Diagnostic And Consulting Services$406.7M$406.7Mvs last quarter +5.3%vs a year ago +11%+5.3%+11%
- Rapid Assay Products$101.6M$101.6Mvs last quarter +20%vs a year ago +1.3%+20%+1.3%
- Veterinary Software Services And Diagnostic Imaging Systems$96.3M$96.3Mvs last quarter +5.5%vs a year ago +12%+5.5%+12%
- Recurring$76.3M$76.3Mvs last quarter +3.8%vs a year ago +11%+3.8%+11%
- CAG Diagnostic Capital Instruments$47.2M$47.2Mvs last quarter +11%vs a year ago -19%+11%-19%
- CAG Diagnostics Service And Accessories$36.1M$36.1Mvs last quarter -1.5%vs a year ago +3.2%-1.5%+3.2%
- Systems And Hardware$20.0M$20.0Mvs last quarter +13%vs a year ago +18%+13%+18%
Diagnostics & Research
The closest names by size in the same industry